Pennsylvania Trust Co Cut Cvs Health (CVS) Holding by $5.58 Million; Baker Avenue Asset Management LP Lifted Its Target Com (TGT) Stake by $406,380

May 23, 2018 - By Marguerite Chambers

Target Corporation (NYSE:TGT) Logo

Baker Avenue Asset Management Lp increased its stake in Target Corp Com (TGT) by 37.53% based on its latest 2017Q4 regulatory filing with the SEC. Baker Avenue Asset Management Lp bought 6,252 shares as the company’s stock rose 4.77% while stock markets declined. The institutional investor held 22,910 shares of the department and specialty retail stores company at the end of 2017Q4, valued at $1.50 million, up from 16,658 at the end of the previous reported quarter. Baker Avenue Asset Management Lp who had been investing in Target Corp Com for a number of months, seems to be bullish on the $38.37B market cap company. The stock decreased 5.14% or $3.88 during the last trading session, reaching $71.59. About 10.29 million shares traded or 93.35% up from the average. Target Corporation (NYSE:TGT) has risen 28.46% since May 23, 2017 and is uptrending. It has outperformed by 16.91% the S&P500.

Pennsylvania Trust Co decreased its stake in Cvs Health Corp (CVS) by 42.49% based on its latest 2017Q4 regulatory filing with the SEC. Pennsylvania Trust Co sold 77,508 shares as the company’s stock declined 17.45% with the market. The institutional investor held 104,904 shares of the medical and nursing services company at the end of 2017Q4, valued at $7.61M, down from 182,412 at the end of the previous reported quarter. Pennsylvania Trust Co who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $66.51 billion market cap company. The stock decreased 0.30% or $0.2 during the last trading session, reaching $65.42. About 2.42M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 23, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It dropped, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. California-based Schwab Charles Inv Management has invested 0.25% in CVS Health Corporation (NYSE:CVS). Veritas (Uk) reported 188,014 shares. Howe And Rusling holds 0.03% of its portfolio in CVS Health Corporation (NYSE:CVS) for 1,970 shares. Retirement Of Alabama has 854,007 shares. Goodman Fincl stated it has 0% in CVS Health Corporation (NYSE:CVS). Cubic Asset Limited Co has 74,884 shares. Fca Tx reported 15,428 shares. Gfs Advsr Lc has 101,978 shares for 1.6% of their portfolio. Columbia Asset Mngmt stated it has 0.14% in CVS Health Corporation (NYSE:CVS). Mcf Advsr Limited Liability Company owns 642 shares for 0.01% of their portfolio. Bontempo Ohly Ltd Llc reported 31,403 shares stake. Girard Ptnrs Ltd stated it has 41,646 shares. Meiji Yasuda Asset Mgmt Communication Limited accumulated 36,027 shares or 0.25% of the stock. Holderness invested in 0.16% or 4,536 shares. Mycio Wealth Partners Limited Liability Company owns 5,144 shares for 0.04% of their portfolio.

Since February 16, 2018, it had 2 buys, and 1 sale for $713,454 activity. 10,000 CVS Health Corporation (NYSE:CVS) shares with value of $619,900 were bought by BROWN C DAVID II. Another trade for 19,965 shares valued at $1.42M was sold by Foulkes Helena.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” on April 26, 2018, also Seekingalpha.com with their article: “CVS: Going Long, And Understanding The Aetna Deal” published on April 30, 2018, Seekingalpha.com published: “We Are Playing The CVS Hand” on May 11, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: 247Wallst.com and their article: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” published on April 29, 2018 as well as Seekingalpha.com‘s news article titled: “Trade Mistake 3: CVS Boredom Trade” with publication date: May 09, 2018.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Wolfe Research downgraded the shares of CVS in report on Wednesday, August 16 to “Hold” rating. On Tuesday, January 30 the stock rating was upgraded by Needham to “Buy”. The company was maintained on Wednesday, August 16 by Jefferies. Needham upgraded the stock to “Buy” rating in Friday, November 10 report. As per Tuesday, April 10, the company rating was maintained by Leerink Swann. Leerink Swann maintained the shares of CVS in report on Friday, February 9 with “Outperform” rating. As per Monday, November 2, the company rating was maintained by Oppenheimer. The stock has “Hold” rating by Loop Capital on Tuesday, November 7. RBC Capital Markets maintained the shares of CVS in report on Wednesday, August 5 with “Outperform” rating. The company was maintained on Thursday, August 17 by Citigroup.

Pennsylvania Trust Co, which manages about $2.24B US Long portfolio, upped its stake in Abbott Labs (NYSE:ABT) by 5,400 shares to 330,869 shares, valued at $18.88 million in 2017Q4, according to the filing. It also increased its holding in Hanesbrands Inc (NYSE:HBI) by 111,085 shares in the quarter, for a total of 206,698 shares, and has risen its stake in Royal Dutch Shell Plc.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 earnings per share, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.16 P/E if the $1.61 EPS becomes a reality. After $1.48 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

More notable recent Target Corporation (NYSE:TGT) news were published by: Benzinga.com which released: “Geopolitics Back In Town, And It Looks Like They Might Weigh On Market” on May 23, 2018, also Fool.com with their article: “Will Target Outshine Walmart This Week?” published on May 21, 2018, Nasdaq.com published: “Mid-Morning Market Update: Markets Open Lower; Target Earnings Miss Views” on May 23, 2018. More interesting news about Target Corporation (NYSE:TGT) were released by: 247Wallst.com and their article: “Target, Hewlett Packard Enterprise and More Earnings Coming This Week” published on May 20, 2018 as well as Seekingalpha.com‘s news article titled: “Traffic strong at Target” with publication date: May 23, 2018.

Among 29 analysts covering Target Corporation (NYSE:TGT), 11 have Buy rating, 3 Sell and 15 Hold. Therefore 38% are positive. Target Corporation had 89 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, January 9, the company rating was maintained by Jefferies. The rating was initiated by Credit Suisse with “Buy” on Monday, March 5. On Wednesday, January 18 the stock rating was maintained by Telsey Advisory Group with “Outperform”. As per Tuesday, January 9, the company rating was maintained by Bank of America. The company was downgraded on Monday, September 12 by Cowen & Co. The stock has “Buy” rating by Susquehanna on Monday, March 5. The rating was maintained by Bernstein with “Buy” on Thursday, December 14. The firm earned “Hold” rating on Monday, May 16 by Deutsche Bank. The firm has “Hold” rating by Robert W. Baird given on Tuesday, January 9. The company was maintained on Thursday, August 20 by M Partners.

Baker Avenue Asset Management Lp, which manages about $1.13B and $1.04B US Long portfolio, decreased its stake in Ishares Russell 1000 Etf (IWB) by 40,874 shares to 50,135 shares, valued at $7.45M in 2017Q4, according to the filing. It also reduced its holding in Ishares Msci Eafe Small (SCZ) by 99,105 shares in the quarter, leaving it with 176,325 shares, and cut its stake in Powershares Senior Loan Portfolio (BKLN).

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>